|
Skincare Meds and COVID-19
|
In this week’s Patient Insights, InStyle details dermal fillers and examines the relationship between skincare meds and COVID-19. Self questions the damaging effects of computer-emitted blue light, Allure highlights Hidradenitis Suppurativa and Vogue explains how stress affects the scalp.
|
|
|
Investigational toxins offer longer duration (DAXI, Revance Therapeutics), short-acting and short-duration benefits (BoNTE, Allergan) and a ready-to-use liquid formulation (QM1114, Galderma).
Skincare company DermYoung launches an initiative with medical spas to donate needed personal protection equipment to hospitals for staff to safeguard from COVID-19.
Dr. Randolph Waldman shares insights, realities and what’s yet to come for the private practice as a result of the Coronavirus crisis.